Let’s Reach Your Development Milestones Together
Ulrike Konrad, MBA
Director, CMC Expert on Biopharmaceuticals and Cell and Gene Therapy Products
Ulrike graduated with a Diploma in Chemistry and MBA after studying at universities in Germany and USA. She started her professional career as a scientist at a biotech company before transitioning to various business development positions. Since 2012, she has led ProtaGene’s international business development activities.
Why work with her:
- 15 years of experience in biopharmaceutical development
- Strong communication skills
- Knowledgeable about cell line development, USP, DSP development, manufacturing, and corresponding analytics
- Broad understanding of solid analytical layouts for your program
Her expert knowledge about biosimilar development, molecules, companies, and regulatory perspectives will guide project discussions and strategies. Whether you are interested in entering the EU market and need EU release testing or you need to demonstrate biosimilarity, contact her!
Analytical Solutions from Research to Market
Biologic Therapeutics
Platform Expertise
-
mAbs
-
Bispecifics/Multispecifics
-
Recombinant Proteins—Including Complex, Highly Glycosylated Proteins
-
Multi-subunit Complexes—Protein, Nucleotide, Ligand
-
Fusion Proteins
-
Enzyme Replacement Therapies
-
ADCs and Protein Conjugates
-
PEGylated Proteins
-
Biosimilars
-
Vaccines, Including Subunit/Recombinant
Cell and Gene Therapeutic Platform Expertise
-
Capsid-based Vectors
-
bullet Created with Sketch. Complex, Envelope Vectors
-
bullet Created with Sketch. Non-viral Vectors
-
bullet Created with Sketch. Genetic Engineering